When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. Available in select countries, the dashboard helps healthcare providers, including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics streamline their diabetes population health management.

Developed for busy healthcare professionals, the new Glooko clinic dashboard is based on TIDE (Timely Interventions for Diabetes Excellence) metrics to help address the challenge of managing a large diabetes patient population. This user-friendly view provides at-a-glance insights into patient population trends and key clinic metrics, making it easier for the entire care team to interpret complex data and guide more efficient decision-making and clinic strategy.

Built on TIDE Metrics for Smarter Diabetes Care

Leveraging evidence-based risk identification logic developed by Stanford researchers to further enhance clinical insights, personalize care, and demonstrate scalable, cost-effective outcomes, the TIDE dashboard, which demonstrated in a 2022 study to reduce screen time for healthcare providers reviewing patient data by 86%, is a powerful tool designed to help clinical teams manage large populations of patients with type 1 diabetes.

The TIDE dashboard uses smart algorithms to analyze and remotely monitor data from continuous glucose monitoring (CGM) devices, helping care teams efficiently and effectively manage their patients’ health. Using essential glucose measures like Time in Range and hypoglycemia, the TIDE model also prioritizes which patients need immediate attention by sorting them by clinical risk, so healthcare providers can focus on those who need it most without sifting through every patient’s data individually.

The TIDE model-based Glooko clinic dashboard offers our professional users a user-friendly way to tackle the challenge of managing a large patient population with three intuitive sections.

Understand Patient Population At-A-Glance

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. This space displays the total number of patients with diabetes, identifies who is actively monitoring their blood glucose by blood glucose monitors (BGM) or CGM, and shows which patients have completed their Glooko account registration and are actively syncing their health data remotely with our connected care platform.

By centralizing these metrics, this comprehensive section of the dashboard helps healthcare providers shape clinic strategy more efficiently and better understand which patients to contact to activate their Glooko account to make more informed decisions based on synced health data.

Prioritize Care Based on Key CGM Metrics

The CGM Patient Risk Stratification section of the new Glooko clinic dashboard helps healthcare providers prioritize patient care and gives care teams a streamlined view of their patient population, sorted by clinical risk based on key glucose metrics from CGMs. Care teams can easily spot which patients need attention first. The dashboard ranks patients using indicators like Time in Range, Time Below Range, and other key CGM indicators, so healthcare providers can prioritize outreach and interventions based on the most important CGM data, making it easier for them to focus their time on the patients who need it most.

Boost Patient Engagement and Optimize Care

The Engagement Metrics module of the new Glooko clinic dashboard helps healthcare providers spot engagement gaps in their patient population over the past 90 days.

The Patient Account Status section examines the patient population to see if they’ve set-up their Glooko account based on Activated, Invited Pending, Never Invited, and Likely Duplicates. With these key metrics, care teams can quickly see which patients with diabetes haven’t completed the sync to Glooko with their diabetes and health monitoring devices as well as the activation process, allowing for more efficient follow-up and activation.

In the Sync Methods section, care teams can see how patients with diabetes are syncing their data with Glooko. When more health data is synced with Glooko from the cloud, Glooko Mobile App, Transmitter, or Uploader, care teams can make more informed and timely treatment decisions.

Experience Glooko’s New Clinic Dashboard

Ready to see how the intuitive, new Glooko clinic dashboard can optimize diabetes population health management at your clinic, hospital, or health system? Contact our team for a demo.

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Introducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

• Population Metrics: This section gives a single, concise, and organized view of the clinic’s total patient population, patients monitoring blood glucose, and those with activated accounts using key engagement and monitoring metrics.
• CGM Patient Risk Stratification: This dashboard, modeled after the Timely Interventions for Diabetes Excellence (TIDE) Dashboard, gives healthcare providers a streamlined view of their patient population, ranked by risk level using key glucose metrics and CGM data only. Care teams can identify risk levels using Time in Range, Time Below Range, and other key CGM indicators to prioritize care.
• Engagement Metrics: This section helps healthcare providers spot engagement gaps within their patient population over the past 90 days and take action to get more patients connected and syncing their devices with Glooko. With more synced health data, care teams can make more informed treatment decisions.

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Updated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

Glooko is excited to showcase how our connected care platform is transforming diabetes care and simplifying diabetes management at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) in Vienna, Austria, from 15 to 19 September 2025.

At booth C6.07 of the international diabetes conference, Team Glooko will provide partners, industry thought leaders, and healthcare professionals with the opportunity to experience our latest innovations.

• Glooko in Action: We’ll provide live demonstrations of the Glooko Web and Mobile App uniquely designed to address the growing complexities in diabetes care and improve health outcomes of people living with diabetes. With Glooko, healthcare providers can simplify diabetes management, reduce administrative burden, and improve clinical workflows to focus more on delivering care and less on managing data.
• Hedia Diabetes Assistant: Glooko’s recent collaboration with Hedia, a trusted bolus calculator already available in the U.K. and Sweden, enhances precision and efficiency for multiple daily insulin dosing. The new integration offers personalised recommendations and streamlined diabetes management for people living with diabetes while providing healthcare professionals with comprehensive insights through Glooko.
• Industry-Leading Device Compatibility: Through our partnerships, Glooko enables people with diabetes to seamlessly sync and analyze health data from more than 200 diabetes and health monitoring devices. This extensive ecosystem, including CGMs, BGMs, insulin pens and pumps, and health and wellness apps, allows for better collaboration with care teams and improved health outcomes.
• EHR Integrations: Glooko is working to expand its capability to sync with EHR systems across Europe, supporting a smoother flow of data between clinical records and our diabetes software. These integrations are designed to help streamline workflows and reduce administrative tasks, enabling healthcare providers to spend more time focusing on efficient, data-driven patient care.

To meet with one of our experts at EASD 2025, schedule a meeting.

We look forward to seeing you in Vienna!

As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.

With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.

Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.

How Glooko integrates with hybrid closed loop systems

Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.

The hybrid closed loop systems that currently sync with Glooko include:

• mylife Loop (CamAPS FX and Ypsomed)
• Tandem Control-IQ
• Insulet Omnipod 5
• Dana CamAPS® FX

Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.

Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).

Benefits of using hybrid closed loop systems with Glooko

There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:

• Major changes in treatment that reduce daily burdens and mental stress
• More time with glucose levels in range with less effort
• The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates

There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:

• An increased monitoring of patients with diabetes who are using closed loop systems
• Strengthening their connection with their patients
• Better management of fluctuations in patients’ glucose levels
• Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses

The future of hybrid closed loop systems

Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.

As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.

For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.

At Glooko, we empower certified diabetes care and education specialists (CDCES) by equipping them with the tools needed to help individuals with Type 1, Type 2, gestational diabetes, and prediabetes better manage their condition and reduce the risk of complications.

Our connected care platform offers remote patient monitoring, compatibility with more than 200 diabetes and health monitoring devices, and easy-to-read reports. With EHR integrations to streamline clinical workflows and population health dashboards, CDCES professionals can proactively identify trends, tailor care plans, and help improve health outcomes — making diabetes care and education more efficient, data-driven, and impactful.

If you’re a CDCES planning to attend the Association of Diabetes Care & Education Specialists’ ADCES25 in Phoenix, Team Glooko wants to meet you at booth #1131 to share the latest updates to our innovative diabetes management platform and mobile app and give you the opportunity to see how we’re transforming diabetes care.

Some of the exciting features and happenings that you can expect to see at our booth:

• Ask An Expert: Our booth will host Glooko Senior Director of Clinical Transformation Trisha Martinez, MBA, RN, BSN, an accomplished clinician, who will share best practices for how CDCESs can educate people living with diabetes to use Glooko to better manage their condition. Our resident clinical expert will be on-site to hear feedback, tips, and tricks for using our connected care platform.
  • Friday, August 8: 9:30-10:15 a.m. and 12:15-2:15 p.m.
  • Saturday, August 9: 9-9:45 a.m., 11:45-1 p.m., and 3-4 p.m.
• Glooko Web and Mobile App: We’ll provide live demos of Glooko, our cutting-edge connected care platform designed to simplify diabetes management and make it easier for people with diabetes to input, view, and understand their health data. Mobile app users can also take advantage of the innovative food tracker feature to easily log their food intake and view their food data alongside data from compatible devices, medications, and exercise. Best of all, the synced data can be securely shared with care teams to stay on track between appointments!
• New Clinic Dashboard: This summer, we’ll launch a new clinic dashboard in Glooko that provides a high-level view of a patient population and program performance across key areas. The Population Metrics panel tracks total patients, CGM use, and activation rates — updated every 14 days — to highlight trends and engagement gaps. CGM Risk Stratification uses CGM data to rank patients by clinical risk, helping prioritize care. Engagement Metrics show where patients are in their onboarding journey and how they sync data, enabling staff to focus outreach and improve engagement efforts.
• EHR Integrations: Glooko seamlessly integrates with leading EHR systems to securely consolidate diabetes data in one place, removing the need to switch platforms or manage multiple logins. This feature allows healthcare providers to work more efficiently within a single interface that offers a comprehensive view of each patient’s health data.
• Latest Device Compatibility: Glooko now integrates with Abbott’s FreeStyle Libre CGMs in the U.S., offering real-time glucose and lifestyle data in one platform, empowering people with diabetes to take better control of their health, and enabling healthcare providers to make more informed, data-driven decisions.

To meet with one of our experts at ADCES25, schedule a meeting.

See you in Phoenix!

The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.

In late June, Glooko was proud to participate in the American Diabetes Association’s 85th Scientific Sessions in Chicago. We had the opportunity to connect with healthcare professionals, device partners, and diabetes community leaders to advance our digital health platform as we continue to power smarter, more efficient diabetes care.

From demonstrating our best-in-class EHR integrations that help simplify clinical workflows to sharing how our connected care solution integrates with more than 200 diabetes and health monitoring devices to drive more informed insights and better health outcomes, our presence at American Diabetes Association’s 85th Scientific Sessions was all about innovation and collaboration.

We were especially excited to host attendees at our Product Theater, where Glooko clinical experts Mark Clements, M.D., Ph.D., and Trisha Martinez, M.B.A., B.S.N., R.N., highlighted the impact of Glooko’s seamless EHR integration assets, tools, and capabilities that help streamline workflows, deliver actionable insights, and better manage patient populations with diabetes. Attendees also received early access to the 2025 Glooko Global Diabetes Report, which features a comprehensive look at how real-world data can drive better outcomes in diabetes care and help shape a smarter, more connected future of diabetes management.

Key ADA 2025 Takeaways from Team Glooko

	Mike Alvarez, CEO, Glooko: “The energy at ADA this year was incredible. I think this clearly signals how fast-moving innovation is in diabetes care. We had so many great conversations with clinicians and partners energized by what Glooko is bringing to the table — and we’re just getting started.”
	Rich Glenn, President, Connected Care, Glooko: “Participating in the ADA’s 85th Scientific Sessions reaffirmed the critical role Glooko plays in advancing connected care. Engaging with healthcare leaders, partners, and innovators gave us valuable insights to continue evolving our platform and ensuring we remain at the forefront of delivering smarter, more efficient diabetes management tools for healthcare providers and people living with diabetes.”
	Trisha Martinez, Senior Director, Clinical Transformation, Glooko: “The event reinforced the importance of data architecture that supports enterprise-level clinical reporting and delivers segmented insights to large health systems. CGMs continue to show promise, and there’s exciting potential for similar innovations in kidney and liver testing that could be tied to outcomes, population health, and prevention of chronic complications. Outpatient tech is evolving, potentially strengthening ties to hospital services. It’s also clear that demonstrating outcomes and integrating more services into the Glooko platform is key to enabling comprehensive disease management.”
	Rachel Beecham, Regional Vice President, Connected Care, South Central, Glooko: “Having the opportunity to spend time with people living with diabetes and their caregivers provided a meaningful perspective on the daily challenges they face and the care they require — deepening my sense of purpose and strengthening the mission behind our work at Glooko.”
	Adam Greenwald, Senior Customer Success Manager, Southwest, Glooko: “As a longtime Glooko employee, the annual American Diabetes Association event enabled me to continue to deepen my diabetes industry knowledge by exploring new cutting-edge diabetes technologies and strengthening connections with my peers, thought leaders, and customers.“

What’s Next? Connect with Team Glooko

Interested in learning more about what Glooko’s diabetes management platform has to offer your hospital, health system, or clinic? Schedule a personalized demo.

This is not part of the 85th Scientific Sessions as planned by the American Diabetes Association®. This content is neither sponsored nor endorsed by the American Diabetes Association®. This content does not qualify for continuing medical education (CME) credit.

The Glooko 2025 Global Diabetes Report offers a comprehensive look at how real-world data can drive better outcomes in diabetes care. Powered by billions of data points across 30+ countries, this report uncovers meaningful trends in glycemic management, technology adoption, and behaviors among people living with Type 1, Type 2, and gestational diabetes.

From the rise of remote monitoring to the impact of advanced technologies like Continuous Glucose Monitors (CGMs) and Automated Insulin Delivery (AID) systems, this report explores how personalized insights can be used to better inform personalized care, predict risk, and guide clinical decision-making.

Whether you’re a clinician, researcher, or innovator in diabetes management technology, this report highlights how data can be turned into action — helping to shape a smarter, more connected future of diabetes management.

Download the report

As part of our ongoing commitment to supporting healthcare providers and people living with diabetes, we’re excited to share the latest enhancements and features now available in Glooko Web 25.1 and Mobile 6.11. These updates are designed to streamline workflows, improve patient engagement and security, and provide care teams with more robust tools to manage diabetes care effectively.

Patient Notes and Medications in Week View

Care teams and people living with diabetes can now view notes and medication entries added to the Glooko Mobile and Web App directly in Week View, both online and in PDF reports. These entries appear in a new collapsible “Events” section below each day, making it easier to contextualize trends in glucose data and treatment behaviors.

Streamlined Week View PDF Reports

In our new release, Week View PDFs are now cleaner and more efficient. Sections without data will be automatically hidden, allowing more patient data over a few days to fit on each page.

The glucose and statistics sections will always remain, and a single, comprehensive legend will now appear at the end of the report.

Smarter Defaults in the PDF Wizard for Hybrid Closed Loop Systems

Designed to streamline reporting workflows and help care teams quickly access the most meaningful insights, the Glooko PDF Wizard now automatically pre-selects the most relevant reports, including Summary, Week, Daily, and Devices, when a patient uses a Hybrid Closed Loop System like Omnipod® 5, Tandem t:slim X2 with Control-IQ technology, or mylife Loop powered by CamAPS® FX.

Care teams can still customize the selections as needed.

Enhanced Security in the Glooko Mobile App

At Glooko, we’re committed to the security and safety of our platform users.

People living with diabetes, including those under age 18, can now manage their login credentials (email and password) through a new Login Security section in the Glooko Mobile App’s Account Settings. We’ve also expanded support for two-factor authentication (2FA) to users to ensure an extra layer of protection.

Explore More Updates

For more detailed information about the new features designed to simplify diabetes management, be sure to check out the full release notes on the Glooko Support Center.

Over the past several months since stepping into the role of CEO at Glooko, I’ve been reflecting on the incredible progress we’ve made, and the immense opportunities that lie ahead. Each day has reaffirmed my belief that our mission to transform diabetes care is both urgent and achievable. I’m more energized than ever to guide Glooko toward a future where we deliver an even greater impact for people with diabetes and those who care for them.

When I think about the future of diabetes care, one word comes to mind: transformation. Across the globe, health systems, clinicians, and people living with diabetes are looking for a holistic approach, one that brings together cutting-edge technology, patient-centric insights, and secure, scalable solutions. At Glooko, we’ve made it our mission to deliver exactly that.

Our Vision: Transforming Diabetes Care

We believe in transforming diabetes care by making it simpler, more connected, and fundamentally centered on people with diabetes. This vision underpins every decision we make, whether we’re enhancing our platform’s EHR integration, partnering with global device manufacturers, or expanding our footprint in new markets.

Our Mission: Simplifying Care and Strengthening Connections

At Glooko, we say: “We simplify care, strengthen connections, and together create a brighter future for people living with diabetes, healthcare providers, and caregivers.”

Simplify Care

We hear time and again about fragmented workflows and siloed data, forcing providers and patients to juggle multiple device platforms (mobile and web), apps, and logins. Our platform intends to change this, meaning clinicians can potentially spend less time on administrative tasks and more time where they’re needed most: caring for patients and focused on improving outcomes.

Strengthen Connections

We also see the power of community and shared decision-making. Through Glooko, patients, caregivers, and healthcare teams can collaborate more effectively, share real-time data, and gain insights that drive meaningful change in care plans. We aim to reduce the cognitive burden of diabetes data and decision making.

In my view, these are the five biggest differentiators that make Glooko stand out:

1. Patient First Mindset: Everything we do revolves around putting patients first. We collaborate closely with clinicians, caregivers, and people living with diabetes to ensure our technology meets real-world needs.
2. Commitment to Quality and Security: From ISO 27001 to HiTrust and SOC 2 Type 2 certifications, our platform is backed by enterprise-grade security and rigorously tested reliability. We understand that healthcare data is precious and that trust is earned through quality.
3. Innovation That Matters: Our platform is more than a “data upload tool.” It’s an engine designed to support clinical decision making. Whether it’s EHR interoperability or automated patient nudges, we constantly push boundaries to develop meaningful solutions that scale globally.
4. High-Performance Culture: Within the company, we’re building a talented, global team that challenges the status quo. This energy fuels our drive to expand into new markets, partner with industry leaders, and improve access to diabetes care around the world.
5. Better Together: Collaboration is in our DNA, and that includes partnerships with device manufacturers, healthcare providers and hospital systems. By joining forces with stakeholders across the healthcare ecosystem, we have the opportunity to create value that benefits everyone, especially people living with diabetes.

Scaling for the Future

Our work has already touched millions of lives, but we’re just getting started. With rising rates of diabetes worldwide, the need for an integrated, secure, and human-centered solution has never been greater. That’s why we’re investing in global expansion, forging new alliances, and refining our platform to make sense of the high volume of data in diabetes care.

Scaling effectively also means staying true to our roots. Our commitment to patient outcomes, uncompromising quality, and secure innovation will remain the bedrock of Glooko’s growth. As we continue to expand, our North Star will always be the same: transforming diabetes care on a global scale and making diabetes easier to manage for everyone in the diabetes care ecosystem.

A Commitment to People Living with Diabetes, Above All

Behind every data point or device upload is a person managing a complex, life-altering condition. We never lose sight of that human element. As Glooko grows, our Patients First value continues to guide us toward solutions that truly make a difference, reducing clinical burdens, improving outcomes, and helping people with diabetes live fuller, healthier lives.

MKT-0532 01

This summer, we have interns across various functions at Glooko who are working in administrative and technical positions. Through their rewarding roles, they’re making an impact at our digital health company and helping us better our connected care technologies that improve the lives of people with diabetes and related chronic conditions.

Meet our summer interns and hear about their experiences at Glooko.

SUMMER INTERNS

Based in California, Salvatore Colli, a supply chain major and senior at Rutgers University-New Brunswick, is working on the corporate finance team on projects aligned with sales. He’s using his knowledge to help guide global data and reporting projects around contracts, lead and accounts within Salesforce. He’s found that Glooko has helped prepare him for his future career in a variety of ways, including perfecting multitasking, getting a better grasp of industry software platforms and learning how to better communicate and be organized. His favorite part of interning has been connecting with his colleagues, who are always insightful, professional and have a sense of humor.

Hailing from Connecticut, Jess Innes, a senior at Southern New Hampshire University, is working on our cybersecurity team. Her projects this summer have included audits, policy revisions and security alerts. Through her work, she believes Glooko is helping prepare her for her future career in cybersecurity. She’s found her team to be very enjoyable while working remotely and getting closer to completing her major in cybersecurity.

Jacob Liclican, a recent graduate from University of San Francisco with a major in marketing, joined our human resources team for the summer. He’s working meticulously on maintaining HR Information Systems (HRIS) records and learning more about databases each day. While Glooko has been teaching him the responsibilities and tasks associated within various departments to prepare him for his future career, he’s also had the opportunity to meet many of his colleagues in-person and virtually who he’s found to be very welcoming and supportive.

Tran Nguyen, a Connecticut-based senior at Southern New Hampshire University majoring in information technology, is spending her summer on our IT operations team. During her experience, she has been able to gain working knowledge of various softwares and processes, audits and policy revisions, while managing multiple help desk tickets from employees. She found her tasks this summer to be very interesting and her teammates to be quite helpful.

In our product management department, Lukas Nykaza, a student at Mahomet-Seymour High School in Illinois, is helping document the activation workflows of the recently redesigned Glooko® Mobile App. At our connected care company this summer, he’s learning if product and data management could be a future career. He’s enjoying the flexibility that Glooko provides to their interns and the opportunity to gain knowledge that he will be able to put to future use.

We’re thankful for all the contributions of our interns this summer!

Interested in furthering your career at Glooko? Explore open roles around the world.

MKT-0483 01